Non-Melanoma Skin Cancer Market

Government initiatives to raise awareness of non-melanoma skin cancer

Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Government authorities and regulatory bodies are working overtime to educate people about non-melanoma skin cancer and its debilitating effect on the nation’s economy.

This is particularly in the developed world. For e.g. – Cancer Council Australia has unveiled the SunSmart program to raise awareness of non-melanoma skin cancer. This could not be done sooner as Australia suffers a great deal from non-melanoma skin cancer and has the highest prevalence in the APAC region.

The Australian Institute of Health and Welfare estimates that skin cancer is the largest cancer diagnosed in the country and nearly 1800 people lost their lives to it in 2016. The A&Z non-melanoma skin cancer treatment market is anticipated to be valued at more than US$ 705 Mn at the end of the forecast period making it larger than the rest of the APAC region combined.

Radiation therapy dominates non-melanoma skin cancer treatment market

Radiation therapy has a market share approaching 90% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon. Radiation therapy has a value of approx. US$ 4.8 Bn by end 2025 making it considerably larger than both chemotherapy and photodynamic therapy. Within radiation therapy, external beam radiation therapy is currently the largest in terms of market value.

However, the highest CAGR of 9.6% for the period 2017-2025 is anticipated to be witnessed in the superficial radiation therapy segment as this newer treatment has relatively lesser side-effects making it preferable for patient health in the long run.

The market attractiveness of radiation therapy in the non-melanoma skin cancer treatment market is expected to be 2.7 and the development of portable radiation therapy devices should further propel the non-melanoma skin cancer treatment market.

Numerous complications linked to conventional radiation therapy

Radiation therapy is used to treat non-melanoma skin cancer lesions in cases where surgery is not possible such as the nose tip, eyelids, and other extremities. Unfortunately, radiation therapy causes serious side-effects depending on the treatment area size, radiation dose, and exposure duration. Some of the complications include edema, skin peeling, skin problems, and hair loss. All these challenges restrain the growth of radiation therapy in the non-melanoma skin cancer treatment market.

Superficial radiation therapy adopted in clinics for lesser side-effects

The development of standalone radiation therapy machines has led to their widespread acceptance in dermatology clinics to treat non-melanoma skin cancer. These highly portable devices are used because they have comparatively lesser side-effects.

Sensus Healthcare has created SRT radiation therapy devices to treat non-melanoma skin cancer as they are a highly effective form of treatment with much lesser side-effects. These devices have the added benefit of being more economical compared to conventional radiation therapy devices. Sensus Healthcare has sold more than 300 superficial radiation therapy devices in the U.S. alone and this number is increasing by the day.

Non-Melanoma Skin Cancer Treatment Market – Taxonomy

Attribute	Details
Treatment Type	Radiation Therapy External Beam Radiation Therapy Electronic Brachytherapy Superficial Radiation Therapy Chemotherapy Photodynamic Therapy
Region	North America Latin America Europe Asia Pacific Middle East & Africa
Indication	Basal Cell Carcinoma Squamous Cell Carcinoma
End User	Hospitals Ambulatory Surgical Centers Specialty Clinics

To know more about delivery timeline for this report Contact Sales